Conditionally Immortalized Mouse Embryonic Fibroblasts Retain Proliferative Activity without Compromising Multipotent Differentiation Potential

Mesenchymal stem cells (MSCs) are multipotent cells which reside in many tissues and can give rise to multiple lineages including bone, cartilage and adipose. Although MSCs have attracted significant attention for basic and translational research, primary MSCs have limited life span in culture which hampers MSCs' broader applications. Here, we investigate if mouse mesenchymal progenitors can be conditionally immortalized with SV40 large T antigen and maintain long-term cell proliferation without compromising their multipotency. Using the system which expresses SV40 large T antigen flanked with Cre/loxP sites, we demonstrate that mouse embryonic fibroblasts (MEFs) can be efficiently immortalized by SV40 large T antigen. The conditionally immortalized MEFs (iMEFs) exhibit an enhanced proliferative activity and maintain long-term cell proliferation, which can be reversed by Cre recombinase. The iMEFs express most MSC markers and retain multipotency as they can differentiate into osteogenic, chondrogenic and adipogenic lineages under appropriate differentiation conditions in vitro and in vivo. The removal of SV40 large T reduces the differentiation potential of iMEFs possibly due to the decreased progenitor expansion. Furthermore, the iMEFs are apparently not tumorigenic when they are subcutaneously injected into athymic nude mice. Thus, the conditionally immortalized iMEFs not only maintain long-term cell proliferation but also retain the ability to differentiate into multiple lineages. Our results suggest that the reversible immortalization strategy using SV40 large T antigen may be an efficient and safe approach to establishing long-term cell culture of primary mesenchymal progenitors for basic and translational research, as well as for potential clinical applications.

[1]  J. Qin,et al.  Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma , 2011, Oncogene.

[2]  T. He,et al.  BMP-9 induced osteogenic differentiation of mesenchymal stem cells: molecular mechanism and therapeutic potential. , 2011, Current gene therapy.

[3]  T. He,et al.  Tetrandrine Inhibits Wnt/β-Catenin Signaling and Suppresses Tumor Growth of Human Colorectal Cancer , 2011, Molecular Pharmacology.

[4]  T. He,et al.  Mesenchymal Progenitor Cells and Their Orthopedic Applications: Forging a Path towards Clinical Trials , 2010, Stem cells international.

[5]  T. He,et al.  Lysophosphatidic Acid Acyltransferase β (LPAATβ) Promotes the Tumor Growth of Human Osteosarcoma , 2010, PloS one.

[6]  Yang Bi,et al.  Mesenchymal stem cells: Molecular characteristics and clinical applications. , 2010, World journal of stem cells.

[7]  T. He,et al.  Retinoic Acids Potentiate BMP9-Induced Osteogenic Differentiation of Mesenchymal Progenitor Cells , 2010, PloS one.

[8]  T. He,et al.  Synergistic Antitumor Effect of the Activated PPARγ and Retinoid Receptors on Human Osteosarcoma , 2010, Clinical Cancer Research.

[9]  T. He,et al.  Activation of RXR and RAR signaling promotes myogenic differentiation of myoblastic C2C12 cells. , 2009, Differentiation; research in biological diversity.

[10]  T. He,et al.  Retinoic acid signalling induces the differentiation of mouse fetal liver‐derived hepatic progenitor cells , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[11]  T. He,et al.  Wnt antagonist SFRP3 inhibits the differentiation of mouse hepatic progenitor cells , 2009, Journal of cellular biochemistry.

[12]  T. He,et al.  BMP‐9‐induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/β‐catenin signalling , 2009, Journal of cellular and molecular medicine.

[13]  T. He,et al.  A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. , 2009, Stem cells and development.

[14]  T. He,et al.  Hey1 Basic Helix-Loop-Helix Protein Plays an Important Role in Mediating BMP9-induced Osteogenic Differentiation of Mesenchymal Progenitor Cells* , 2009, Journal of Biological Chemistry.

[15]  A. Montag,et al.  Osteogenic BMPs promote tumor growth of human osteosarcomas that harbor differentiation defects , 2008, Laboratory Investigation.

[16]  Sheng Ding,et al.  Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. , 2008, Cell stem cell.

[17]  C. Kaps,et al.  Human mastoid periosteum‐derived stem cells: promising candidates for skeletal tissue engineering , 2008, Journal of tissue engineering and regenerative medicine.

[18]  R. Zhao,et al.  Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. , 2008, Cell Stem Cell.

[19]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[20]  F. Djouad,et al.  Mesenchymal Stem Cells Inhibit the Differentiation of Dendritic Cells Through an Interleukin‐6‐Dependent Mechanism , 2007, Stem cells.

[21]  T. Ichisaka,et al.  Generation of germline-competent induced pluripotent stem cells , 2007, Nature.

[22]  A. Montag,et al.  Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells , 2007, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[23]  K. Kinzler,et al.  A protocol for rapid generation of recombinant adenoviruses using the AdEasy system , 2007, Nature Protocols.

[24]  M. Hollstein,et al.  MEF immortalization to investigate the ins and outs of mutagenesis. , 2006, Carcinogenesis.

[25]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[26]  P. Klatt,et al.  Expression of mTert in primary murine cells links the growth-promoting effects of telomerase to transforming growth factor-β signaling , 2006, Oncogene.

[27]  Anoop P. Patel,et al.  Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma. , 2006, Blood.

[28]  Lindolfo da Silva Meirelles,et al.  Mesenchymal stem cells reside in virtually all post-natal organs and tissues , 2006, Journal of Cell Science.

[29]  A. Montag,et al.  CCN1/Cyr61 Is Regulated by the Canonical Wnt Signal and Plays an Important Role in Wnt3A-Induced Osteoblast Differentiation of Mesenchymal Stem Cells , 2006, Molecular and Cellular Biology.

[30]  G. Keilhoff,et al.  Transdifferentiation of mesenchymal stem cells into Schwann cell-like myelinating cells. , 2006, European journal of cell biology.

[31]  S. Wislet-Gendebien,et al.  Astrocytic and neuronal fate of mesenchymal stem cells expressing nestin , 2005, Brain Research Bulletin.

[32]  Robert M Hoffman,et al.  Implanted hair follicle stem cells form Schwann cells that support repair of severed peripheral nerves. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[33]  W. Ansorge,et al.  Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. , 2005, Experimental hematology.

[34]  M. Hande,et al.  Ectopic mTERT expression in mouse embryonic stem cells does not affect differentiation but confers resistance to differentiation- and stress-induced p53-dependent apoptosis , 2005, Journal of Cell Science.

[35]  A. Montag,et al.  Connective Tissue Growth Factor (CTGF) Is Regulated by Wnt and Bone Morphogenetic Proteins Signaling in Osteoblast Differentiation of Mesenchymal Stem Cells* , 2004, Journal of Biological Chemistry.

[36]  F. Claas,et al.  Isolation of Mesenchymal Stem Cells of Fetal or Maternal Origin from Human Placenta , 2004, Stem cells.

[37]  D. van der Kooy,et al.  Facile isolation and the characterization of human retinal stem cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[38]  L. Martin,et al.  Pluripotent fates and tissue regenerative potential of adult olfactory bulb neural stem and progenitor cells. , 2004, Journal of neurotrauma.

[39]  H. Lerche,et al.  Efficient generation of neural stem cell-like cells from adult human bone marrow stromal cells , 2004, Journal of Cell Science.

[40]  J. Szatkowski,et al.  Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery , 2004, Gene Therapy.

[41]  Mark P. Lewis,et al.  Human adult craniofacial muscle‐derived cells: neural‐cell adhesion‐molecule (NCAM; CD56)‐expressing cells appear to contain multipotential stem cells , 2004, Biotechnology and applied biochemistry.

[42]  Wei Jiang,et al.  Inhibitor of DNA Binding/Differentiation Helix-Loop-Helix Proteins Mediate Bone Morphogenetic Protein-induced Osteoblast Differentiation of Mesenchymal Stem Cells* , 2004, Journal of Biological Chemistry.

[43]  Hongwei Cheng,et al.  Transcriptional characterization of bone morphogenetic proteins (BMPs)‐mediated osteogenic signaling , 2003, Journal of cellular biochemistry.

[44]  Richard Tuli,et al.  Adult mesenchymal stem cells and cell-based tissue engineering , 2002, Arthritis research & therapy.

[45]  F. Djouad,et al.  Regenerative medicine through mesenchymal stem cells for bone and cartilage repair. , 2002, Current opinion in investigational drugs.

[46]  A. Montag,et al.  Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[47]  S. Bruder,et al.  Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. , 2001, Trends in molecular medicine.

[48]  M. Nitta,et al.  Characterization and tumorigenicity of human ovarian surface epithelial cells immortalized by SV40 large T antigen. , 2001, Gynecologic oncology.

[49]  H. Lorenz,et al.  Multilineage cells from human adipose tissue: implications for cell-based therapies. , 2001, Tissue engineering.

[50]  K. Kinzler,et al.  PPARδ Is an APC-Regulated Target of Nonsteroidal Anti-Inflammatory Drugs , 1999, Cell.

[51]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[52]  S. Ogawa,et al.  Cardiomyocytes can be generated from marrow stromal cells in vitro. , 1999, The Journal of clinical investigation.

[53]  W. Hahn,et al.  Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[54]  A. Sparks,et al.  Identification of c-MYC as a target of the APC pathway. , 1998, Science.

[55]  D. Prockop Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues , 1997, Science.

[56]  P. Leboulch,et al.  Reversible immortalization of mammalian cells mediated by retroviral transfer and site-specific recombination. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[57]  S. Temple,et al.  A self-renewing multipotential stem cell in embryonic rat cerebral cortex , 1994, Nature.

[58]  C. Cole,et al.  The ability of simian virus 40 large T antigen to immortalize primary mouse embryo fibroblasts cosegregates with its ability to bind to p53 , 1991, Journal of virology.

[59]  C. Prives The replication functions of SV40 T antigen are regulated by phosphorylation , 1990, Cell.

[60]  F. Dean,et al.  Binding and unwinding—How T antigen engages the SV40 origin of DNA replication , 1990, Cell.

[61]  W. Topp,et al.  Tumorigenicity of SV40-transformed human and monkey cells in immunodeficient mice. , 1983, Virology.

[62]  H. Harris,et al.  Tumorigenicity of cells transformed by Simian virus 40 and of hybrids between such cells and normal diploid cells. , 1979, Journal of cell science.

[63]  S. Aaronson,et al.  Development of 3T3‐like lines from Balb/c mouse embryo cultures: Transformation susceptibility to SV40 , 1968, Journal of cellular physiology.

[64]  B. Thiers Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2008 .

[65]  N. Park,et al.  Extension of cell life span using exogenous telomerase. , 2007, Methods in molecular biology.

[66]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[67]  M. Bjerknes,et al.  Intestinal epithelial stem cells and progenitors. , 2006, Methods in enzymology.

[68]  F. Benvenuto,et al.  Human mesenchymal stem cells modulate B-cell functions. , 2006, Blood.

[69]  J. Szatkowski,et al.  Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). , 2003, The Journal of bone and joint surgery. American volume.

[70]  K. Kinzler,et al.  A simplified system for generating recombinant adenoviruses. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[71]  C. Stewart,et al.  Derivation of embryonic stem cell lines. , 1993, Methods in enzymology.

[72]  N. Howell Suppression of transformation and tumorigenicity in interspecies hybrids of human SV40-transformed and mouse 3T3 cell lines. , 1982, Cytogenetics and Cell Genetics.